Lariago 64.5 Injection 2ml is a prescription drug, available for use as Injection. Malaria are some of its major therapeutic uses.

The right dosage of Lariago 64.5 Injection 2ml depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.

While these are the most often observed Lariago 64.5 Injection 2ml side effects, there are can be others also. These have been listed below. Usually, these side effects of Lariago 64.5 Injection 2ml go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.

It is also important to note that Lariago 64.5 Injection 2ml has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Lariago 64.5 Injection 2ml's effects on the liver, heart and kidney are discussed below in the Lariago 64.5 Injection 2ml related warnings section.

Lariago 64.5 Injection 2ml can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lariago 64.5 Injection 2ml in conditions like Porphyria. Some other conditions that can be affected by Lariago 64.5 Injection 2ml are listed in the contraindications section below.

Drug interactions for Lariago 64.5 Injection 2ml have been reported in the medical literature. See below for a complete list.

In addition to these precautions, you may also note that Lariago 64.5 Injection 2ml is not safe while driving, and is is not addictive in nature.